title: [Herpes zoster in cancer patients].
abstract: In cancer patients, the development of herpes zoster (HZ) is accompanied by protracted period of skin rash exudation and by slower scab rejection. Unlike hematological patients, no unfavourable outcomes with infection generalization are observed. The disease is associated with the rise of the content of total IgM, IgA (to a lesser degree) and with the normal level of IgG. There is a tendency towards the reduction of the count of T and B lymphocytes. The cases of primary diagnosis of a malignant tumor in HZ patients are more frequent (2 out of 36).
authors.forename: B P
authors.initials: BP
authors.lastname: Bogomolov
authors.forename: E G
authors.initials: EG
authors.lastname: Bakhur
mesh_terms: D000368:Aged; D000917:Antibody Formation / Q000276:immunology; D005260:Female; D006562:Herpes Zoster / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000276:immunology
vernacular_title: Opoiasyvaiushchiĭ gerpes u onkologicheskikh bol'nykh.